Literature DB >> 382757

Mouse lung oedema caused by a toxic substance of Escherichia coli strains.

I Kétyi, L Emödy, T Kontrohr, A Vertényi, S Pácsa, T A Avdeeva, N V Safonova, N K Golutova.   

Abstract

Some Escherichia coli strains isolated from patients and instilled into the nostrils of mice cause a rapidly developing fatal, haemorrhagic lung oedema. Lung toxic strains were found in different serogroups, with the predominance of 04, 06, and 018. The toxic material seems to be bound to the cells; the toxin yield is poor by different methods of extraction. The toxic principle causes toxic, haemorrhagic oedema in mouse foot pad test and shows cytotoxicity for AV-3 cells. The "lung toxin" is heat labile and after Sephadex fractionation has a molecular weight of about 100 000 dalton. There is a possible identity with a toxic haemolysin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 382757

Source DB:  PubMed          Journal:  Acta Microbiol Acad Sci Hung        ISSN: 0001-6187


  6 in total

Review 1.  The different hemolysins of Escherichia coli.

Authors:  L Beutin
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

Review 2.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

Review 3.  Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity.

Authors:  S J Cavalieri; G A Bohach; I S Snyder
Journal:  Microbiol Rev       Date:  1984-12

4.  Hemolysin plasmid coding for the virulence of a nephropathogenic Escherichia coli strain.

Authors:  C Waalwijk; J F van den Bosch; D M MacLaren; J de Graaff
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

5.  In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants.

Authors:  A K May; R G Sawyer; T Gleason; A Whitworth; T L Pruett
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  Cytotoxic effect of an alpha-hemolytic Escherichia coli strain on human blood monocytes and granulocytes in vitro.

Authors:  O V Gadeberg; I Orskov; J M Rhodes
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.